ARMT
SPRY icon

Amica Retiree Medical Trust’s ARS Pharmaceuticals SPRY Stock Holding History

Amica Retiree Medical Trust’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3K Hold
346
– – ﹤0.01% 141
2025
Q2 		$6K Hold
346
– – 0.01% 136
2025
Q1 		$4K Sell
346
-62
-15% -$746 0.01% 133
2024
Q4 		$4K Buy
+408
New +$5.71K ﹤0.01% 135

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Amica Retiree Medical Trust's SPRY Position: Q3 2025 in Review

Amica Retiree Medical Trust held its ARS Pharmaceuticals (SPRY) position steady in Q3 2025 at 346 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

Amica Retiree Medical Trust first reported a position in SPRY in Q4 2024 and has held it in 4 quarters since. The position peaked at $6K in Q2 2025. 188 funds tracked by Wall St. Rank hold SPRY as of Q3 2025.

  • Amica Retiree Medical Trust held 346 shares of ARS Pharmaceuticals worth $3K as of Q3 2025.
  • Amica Retiree Medical Trust left its ARS Pharmaceuticals share count unchanged in Q3 2025.
  • ARS Pharmaceuticals made up ﹤0.01% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #141 holding.
  • Amica Retiree Medical Trust first reported a position in ARS Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Amica Retiree Medical Trust's ARS Pharmaceuticals position peaked at $6K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2025.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.